{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:36:41Z","timestamp":1761676601895},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1038\/emm.2017.217","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T08:01:16Z","timestamp":1512720076000},"page":"e410-e410","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["IL-11 promotes the treatment efficacy of hematopoietic stem cell transplant therapy in aplastic anemia model mice through a NF-\u03baB\/microRNA-204\/thrombopoietin regulatory axis"],"prefix":"10.1038","volume":"49","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-yun","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-jie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-ru","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"BFemm2017217_CR1","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","volume":"108","author":"NS Young","year":"2006","unstructured":"Young NS, Calado RT, Scheinberg P . Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006; 108: 2509\u20132519.","journal-title":"Blood"},{"key":"BFemm2017217_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12984","volume":"505","author":"SJ Morrison","year":"2014","unstructured":"Morrison SJ, Scadden DT . The bone marrow niche for haematopoietic stem cells. Nature 2014; 505: 327\u2013334.","journal-title":"Nature"},{"key":"BFemm2017217_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1586\/ehm.11.11","volume":"4","author":"AE DeZern","year":"2011","unstructured":"DeZern AE, Brodsky RA . Clinical management of aplastic anemia. Expert Rev Hematol 2011; 4: 221\u2013230.","journal-title":"Expert Rev Hematol"},{"key":"BFemm2017217_CR4","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390\u20133400.","journal-title":"Blood"},{"key":"BFemm2017217_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0140-6736(04)16724-X","volume":"364","author":"AM Risitano","year":"2004","unstructured":"Risitano AM, Maciejewski JP, Green S, Plasilova M, Zeng W, Young NS . In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 2004; 364: 355\u2013364.","journal-title":"Lancet"},{"key":"BFemm2017217_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/cei.12605","volume":"180","author":"Y Zeng","year":"2015","unstructured":"Zeng Y, Katsanis E . The complex pathophysiology of acquired aplastic anaemia. Clin Exp Immunol 2015; 180: 361\u2013370.","journal-title":"Clin Exp Immunol"},{"key":"BFemm2017217_CR7","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1182\/blood-2002-04-1134","volume":"101","author":"N Frickhofen","year":"2003","unstructured":"Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H, German Aplastic Anemia Study G. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 2003; 101: 1236\u20131242.","journal-title":"Blood"},{"key":"BFemm2017217_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1182\/asheducation-2013.1.76","volume":"2013","author":"NS Young","year":"2013","unstructured":"Young NS . Current concepts in the pathophysiology and treatment of aplastic anemia. Hematol-Am Soc Hemat 2013; 2013: 76\u201381.","journal-title":"Hematol-Am Soc Hemat"},{"key":"BFemm2017217_CR9","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1182\/blood-2007-01-066258","volume":"110","author":"EE Solomou","year":"2007","unstructured":"Solomou EE, Rezvani K, Mielke S, Malide D, Keyvanfar K, Visconte V et al. Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood 2007; 110: 1603\u20131606.","journal-title":"Blood"},{"key":"BFemm2017217_CR10","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1182\/blood-2010-01-266098","volume":"116","author":"RP de Latour","year":"2010","unstructured":"de Latour RP, Visconte V, Takaku T, Wu C, Erie AJ, Sarcon AK et al. Th17 immune responses contribute to the pathophysiology of aplastic anemia. Blood 2010; 116: 4175\u20134184.","journal-title":"Blood"},{"key":"BFemm2017217_CR11","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood-2011-08-368308","volume":"119","author":"S Kordasti","year":"2012","unstructured":"Kordasti S, Marsh J, Al-Khan S, Jiang J, Smith A, Mohamedali A et al. Functional characterization of CD4+ T cells in aplastic anemia. Blood 2012; 119: 2033\u20132043.","journal-title":"Blood"},{"key":"BFemm2017217_CR12","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1172\/JCI200112687","volume":"108","author":"W Zeng","year":"2001","unstructured":"Zeng W, Maciejewski JP, Chen G, Young NS . Limited heterogeneity of T cell receptor BV usage in aplastic anemia. J Clin Invest 2001; 108: 765\u2013773.","journal-title":"J Clin Invest"},{"key":"BFemm2017217_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2141.2003.04729.x","volume":"124","author":"NC Giannakoulas","year":"2004","unstructured":"Giannakoulas NC, Karakantza M, Theodorou GL, Pagoni M, Galanopoulos A, Kakagianni T et al. Clinical relevance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in aplastic anaemia patients. Brit J Haematol 2004; 124: 97\u2013105.","journal-title":"Brit J Haematol"},{"key":"BFemm2017217_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12032-015-0647-2","volume":"32","author":"F Zhu","year":"2015","unstructured":"Zhu F, Qiao J, Zhong XM, Wu QY, Chen W, Yao Y et al. Antithymocyte globulin combined with cyclosporine A down-regulates T helper 1 cells by modulating T cell immune response cDNA 7 in aplastic anemia. Med Oncol 2015; 32: 197.","journal-title":"Med Oncol"},{"key":"BFemm2017217_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/107999001459123","volume":"21","author":"M Bozza","year":"2001","unstructured":"Bozza M, Bliss JL, Dorner AJ, Trepicchio WL . Interleukin-11 modulates Th1\/Th2 cytokine production from activated CD4+ T cells. J Interf Cytok Res 2001; 21: 21\u201330.","journal-title":"J Interf Cytok Res"},{"key":"BFemm2017217_CR16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCULATIONAHA.109.893677","volume":"121","author":"M Obana","year":"2010","unstructured":"Obana M, Maeda M, Takeda K, Hayama A, Mohri T, Yamashita T et al. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction. Circulation 2010; 121: 684\u2013691.","journal-title":"Circulation"},{"key":"BFemm2017217_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1600-051X.2008.01212.x","volume":"35","author":"OO Yucel","year":"2008","unstructured":"Yucel OO, Berker E, Gariboglu S, Otlu H . Interleukin-11, interleukin-1beta, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. J Clinic Periodontol 2008; 35: 365\u2013370.","journal-title":"J Clinic Periodontol"},{"key":"BFemm2017217_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/gut.2004.041749","volume":"54","author":"RW Summers","year":"2005","unstructured":"Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV . Trichuris suis therapy in Crohn's disease. Gut 2005; 54: 87\u201390.","journal-title":"Gut"},{"key":"BFemm2017217_CR19","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1182\/blood.V97.9.2758","volume":"97","author":"A Curti","year":"2001","unstructured":"Curti A, Ratta M, Corinti S, Girolomoni G, Ricci F, Tazzari P et al. Interleukin-11 induces Th2 polarization of human CD4(+) T cells. Blood 2001; 97: 2758\u20132763.","journal-title":"Blood"},{"key":"BFemm2017217_CR20","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1200\/JCO.2001.19.21.4165","volume":"19","author":"R Kurzrock","year":"2001","unstructured":"Kurzrock R, Cortes J, Thomas DA, Jeha S, Pilat S, Talpaz M . Pilot study of low-dose interleukin-11 in patients with bone marrow failure. J Clinic Oncol 2001; 19: 4165\u20134172.","journal-title":"J Clinic Oncol"},{"key":"BFemm2017217_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/annonc\/mdi007","volume":"16","author":"AM Tsimberidou","year":"2005","unstructured":"Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA et al. Low-dose interleukin-11 in patients with bone marrow failure: update of the MD Anderson Cancer Center experience. Ann Oncol 2005; 16: 139\u2013145.","journal-title":"Ann Oncol"},{"key":"BFemm2017217_CR22","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1182\/blood.V89.11.3897","volume":"89","author":"X Du","year":"1997","unstructured":"Du X, Williams DA . Interleukin-11: review of molecular, cell biology, and clinical use. Blood 1997; 89: 3897\u20133908.","journal-title":"Blood"},{"key":"BFemm2017217_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-59745-409-4_2","volume":"506","author":"YY Ng","year":"2009","unstructured":"Ng YY, Baert MR, de Haas EF, Pike-Overzet K, Staal FJ . Isolation of human and mouse hematopoietic stem cells. Methods Mol Biol 2009; 506: 13\u201321.","journal-title":"Methods Mol Biol"},{"key":"BFemm2017217_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-62703-317-6_1","volume":"976","author":"K Rector","year":"2013","unstructured":"Rector K, Liu Y, Van Zant G . Comprehensive hematopoietic stem cell isolation methods. Methods Mol Biol 2013; 976: 1\u201315.","journal-title":"Methods Mol Biol"},{"key":"BFemm2017217_CR25","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.4049\/jimmunol.159.11.5661","volume":"159","author":"WL Trepicchio","year":"1997","unstructured":"Trepicchio WL, Wang L, Bozza M, Dorner AJ . IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB. J Immunol 1997; 159: 5661\u20135670.","journal-title":"J Immunol"},{"key":"BFemm2017217_CR26","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/gb-2010-11-8-r90","volume":"11","author":"D Betel","year":"2010","unstructured":"Betel D, Koppal A, Agius P, Sander C, Leslie C . Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 2010; 11: R90.","journal-title":"Genome Biol"},{"key":"BFemm2017217_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-59745-182-6_11","volume":"430","author":"Y Zhan","year":"2008","unstructured":"Zhan Y, Zhao Y . Hematopoietic stem cell transplant in mice by intra-femoral injection. Methods Mol Biol 2008; 430: 161\u2013169.","journal-title":"Methods Mol Biol"},{"key":"BFemm2017217_CR28","doi-asserted-by":"publisher","first-page":"H569","DOI":"10.1152\/ajpheart.00060.2012","volume":"303","author":"M Obana","year":"2012","unstructured":"Obana M, Miyamoto K, Murasawa S, Iwakura T, Hayama A, Yamashita T et al. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart. Am J Physiol Heart Circ Physiol 2012; 303: H569\u2013H577.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFemm2017217_CR29","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1136\/gutjnl-2011-300539","volume":"61","author":"M Howlett","year":"2012","unstructured":"Howlett M, Chalinor HV, Buzzelli JN, Nguyen N, van Driel IR, Bell KM et al. IL-11 is a parietal cell cytokine that induces atrophic gastritis. Gut 2012; 61: 1398\u20131409.","journal-title":"Gut"},{"key":"BFemm2017217_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2739\/kurumemedj.54.73","volume":"54","author":"K Honma","year":"2007","unstructured":"Honma K, Koles NL, Alam HB, Keith JC Jr, Pollack M . Dose-dependent effects of recombinant human interleukin-11 on the systemic hemodynamic function and urination. Kurume Med J 2007; 54: 73\u201376.","journal-title":"Kurume Med J"},{"key":"BFemm2017217_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0300-483X(01)00371-7","volume":"162","author":"RV Lezama","year":"2001","unstructured":"Lezama RV, Escorcia EB, Torres AM, Aguilar RT, Ram\u0131rez CG . Lorenzana MGa et al. A model for the induction of aplastic anemia by subcutaneous administration of benzene in mice. Toxicology 2001; 162: 179\u2013191.","journal-title":"Toxicology"},{"key":"BFemm2017217_CR32","doi-asserted-by":"publisher","first-page":"D140","DOI":"10.1093\/nar\/gkj112","volume":"34","author":"S Griffiths-Jones","year":"2006","unstructured":"Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ . miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34: D140\u2013D144.","journal-title":"Nucleic Acids Res"},{"key":"BFemm2017217_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nri2708","volume":"10","author":"RM O'Connell","year":"2010","unstructured":"O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D . Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111\u2013122.","journal-title":"Nat Rev Immunol"},{"key":"BFemm2017217_CR34","doi-asserted-by":"publisher","first-page":"14229","DOI":"10.1073\/pnas.0913574107","volume":"107","author":"S Guo","year":"2010","unstructured":"Guo S, Lu J, Schlanger R, Zhang H, Wang JY, Fox MC et al. MicroRNA miR-125a controls hematopoietic stem cell number. Proc Natl Acad Sci USA 2010; 107: 14229\u201314234.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2017217_CR35","doi-asserted-by":"publisher","first-page":"21505","DOI":"10.1073\/pnas.1016218107","volume":"107","author":"AG Ooi","year":"2010","unstructured":"Ooi AG, Sahoo D, Adorno M, Wang Y, Weissman IL, Park CY . MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proc Natl Acad Sci USA 2010; 107: 21505\u201321510.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2017217_CR36","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.stem.2012.09.001","volume":"11","author":"ER Lechman","year":"2012","unstructured":"Lechman ER, Gentner B, van Galen P, Giustacchini A, Saini M, Boccalatte FE et al. Attenuation of miR-126 activity expands HSC in vivo without exhaustion. Cell Stem Cell 2012; 11: 799\u2013811.","journal-title":"Cell Stem Cell"},{"key":"BFemm2017217_CR37","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3324\/haematol.2015.126128","volume":"100","author":"K Hosokawa","year":"2015","unstructured":"Hosokawa K, Muranski P, Feng X, Keyvanfar K, Townsley DM, Dumitriu B et al. Identification of novel microRNA signatures linked to acquired aplastic anemia. Haematologica 2015; 100: 1534\u20131545.","journal-title":"Haematologica"},{"key":"BFemm2017217_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3324\/haematol.2016.151076","volume":"102","author":"K Hosokawa","year":"2017","unstructured":"Hosokawa K, Kajigaya S, Feng X, Desierto MJ, Fernandez Ibanez MD, Rios O et al. A plasma microRNA signature as a biomarker for acquired aplastic anemia. Haematologica 2017; 102: 69\u201378.","journal-title":"Haematologica"},{"key":"BFemm2017217_CR39","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.18632\/oncotarget.14046","volume":"8","author":"YX Sun","year":"2017","unstructured":"Sun YX, Li H, Feng Q, Li X, Yu YY, Zhou LW et al. Dysregulated miR34a\/diacylglycerol kinase zeta interaction enhances T-cell activation in acquired aplastic anemia. Oncotarget 2017; 8: 6142\u20136154.","journal-title":"Oncotarget"},{"key":"BFemm2017217_CR40","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/abbs\/gmu082","volume":"46","author":"J Zhao","year":"2014","unstructured":"Zhao J, Wang C, Song Y, Fang B . Arsenic trioxide and microRNA-204 display contrary effects on regulating adipogenic and osteogenic differentiation of mesenchymal stem cells in aplastic anemia. Acta Biochim Biophys Sin (Shanghai) 2014; 46: 885\u2013893.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"BFemm2017217_CR41","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cell.2005.08.020","volume":"122","author":"LA Boyer","year":"2005","unstructured":"Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005; 122: 947\u2013956.","journal-title":"Cell"},{"key":"BFemm2017217_CR42","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1158\/0008-5472.CAN-12-2895","volume":"73","author":"Z Ying","year":"2013","unstructured":"Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H et al. Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. Cancer Res 2013; 73: 990\u2013999.","journal-title":"Cancer Res"},{"key":"BFemm2017217_CR43","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1093\/nar\/gkr006","volume":"39","author":"S Galardi","year":"2011","unstructured":"Galardi S, Mercatelli N, Farace MG, Ciafre SA . NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. Nucleic Acids Res 2011; 39: 3892\u20133902.","journal-title":"Nucleic Acids Res"},{"key":"BFemm2017217_CR44","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1182\/blood-2014-08-594796","volume":"125","author":"C Arieta Kuksin","year":"2015","unstructured":"Arieta Kuksin C, Gonzalez-Perez G, Minter LM . CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltration in a mouse model of aplastic anemia. Blood 2015; 125: 2087\u20132094.","journal-title":"Blood"},{"key":"BFemm2017217_CR45","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.4161\/cc.10.10.15619","volume":"10","author":"CA de Graaf","year":"2011","unstructured":"de Graaf CA, Metcalf D . Thrombopoietin and hematopoietic stem cells. Cell Cycle 2011; 10: 1582\u20131589.","journal-title":"Cell Cycle"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/emm2017217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/emm2017217","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/emm.2017.217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/emm2017217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T19:32:49Z","timestamp":1693337569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/emm2017217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["BFemm2017217"],"URL":"https:\/\/doi.org\/10.1038\/emm.2017.217","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"26 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}